Stoppel Laura — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Stoppel Laura has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
Laura Stoppel is identified in SEC filings as a director associated with Acumen Pharmaceuticals, Inc. as of the filing date 2026-06-05. The available SEC context confirms board governance involvement with Acumen Pharmaceuticals but does not provide additional details about her background, prior roles, education, or other affiliations. This entry focuses on the individual connected to Acumen Pharmaceuticals, Inc. by the cited SEC documentation and acknowledges potential name variations (e.g., Stoppel Laura vs. Laura Stoppel).
Role
Director
Notability
20/100
Board memberships
Acumen Pharmaceuticals, Inc.
Awards & honors
Director on the board of Acumen Pharmaceuticals, Inc. (as of 2026-06-05)
Laura Stoppel is identified in SEC filings as a director associated with Acumen Pharmaceuticals, Inc. as of the filing date 2026-06-05. The available SEC context confirms board governance involvement with Acumen Pharmaceuticals but does not provide additional details about her background, prior roles, education, or other affiliations. This entry focuses on the individual connec…
How many SEC Form 4 filings has Stoppel Laura submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Stoppel Laura's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
